Trademark: 87451183
Word
KNOX MEDICAL
Status
Registered
Status Code
700
Status Date
Tuesday, September 4, 2018
Serial Number
87451183
Registration Number
5557249
Registration Date
Tuesday, September 4, 2018
Mark Type
4000
Filing Date
Tuesday, May 16, 2017

Trademark Owner History
Cansortium Holdings, LLC - Original Registrant

Classifications
5 Pharmaceuticals and nutraceuticals for the treatment of pain, palliative care, nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, Multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritides and musculoskeletal disorders, movement disorders, glaucoma, asthma, hypertension, psychiatric disorders, anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, Alzheimer's disease, dementia, inflammation, inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, inflammatory bowel diseases, diseases of the liver, metabolic syndrome, obesity, diabetes, diseases of the pancreas, anti-neoplastic properties, and atherosclerosis; prescription synthetic narcotics for medical use; pharmaceutical preparations for the treatment of pain, palliative care, nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, Multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritides and musculoskeletal disorders, movement disorders, glaucoma, asthma, hypertension, psychiatric disorders, anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, Alzheimer's disease, dementia, inflammation, inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, inflammatory bowel diseases, diseases of the liver, metabolic syndrome, obesity, diabetes, diseases of the pancreas, anti-neoplastic properties, and atherosclerosis; none of the forgoing containing marijuana or extracts therefrom
35 Retail drug store and pharmaceutical dispensary services that not do not feature goods containing cannabinoids or cannabis
44 Providing health information in the field of medical marijuana and regarding the indications and effects of particular cannabinoids; providing information pertaining to the benefits of the medicinal use of cannabis to treat certain ailments
42 Product research and development, not including marijuana or extracts therefrom
"MEDICAL"

Trademark Events
Sep 4, 2023
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
May 26, 2021
Assignment Of Ownership Not Updated Automatically
Sep 4, 2018
Registered-Supplemental Register
Jul 30, 2018
Law Office Publication Review Completed
Jul 17, 2018
Approved For Registration Supplemental Register
Jul 17, 2018
Examiner's Amendment Entered
Jul 17, 2018
Notification Of Examiners Amendment E-Mailed
Jul 17, 2018
Examiners Amendment E-Mailed
Jul 17, 2018
Examiners Amendment -Written
Jun 27, 2018
Teas/Email Correspondence Entered
Jun 27, 2018
Correspondence Received In Law Office
Jun 22, 2018
Assigned To Lie
Jun 8, 2018
Teas Response To Office Action Received
Apr 21, 2018
Teas Change Of Correspondence Received
Apr 18, 2018
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 18, 2018
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 11, 2017
Notification Of Non-Final Action E-Mailed
Dec 11, 2017
Non-Final Action E-Mailed
Dec 11, 2017
Non-Final Action Written
Dec 5, 2017
Assigned To Examiner
Jun 1, 2017
Assigned To Examiner
May 22, 2017
New Application Office Supplied Data Entered
May 19, 2017
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24